Brief: Aprea Therapeutics Inc Reports Quarterly Net Loss Of $2.4 Million Or $0.92 Per Basic Share
March 30 (Reuters) - Aprea Therapeutics Inc APRE.O :
* APREA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES UPDATE ON BUSINESS OPERATIONS
* APREA THERAPEUTICS INC-QTRLY NET LOSS OF $2.4 MILLION OR
$0.92
PER BASIC SHARE
Source text for Eikon: ID:nGNX9qdRc3
Further company coverage: APRE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aprea Therapeutics
See all newsAprea Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Aprea Therapeutics Q2 net loss widens on higher R&D costs
Aprea Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Aprea Therapeutics Provides Acesot-1051 Program Update For Wee1 Inhibitor Apr-1051 Accelerating And Expanding Enrollment. Clinical Data Presentation Planned For Q4 2026
Brief: Aprea Therapeutics - Files For Resale Of Up To 5.5 Million Shares By Selling Stockholders - SEC Filing